Showing results (1-10 of 37) with videos related to
Sort By:
Pageof 4
Oncoimmunology|March 8, 2014
Human papillomavirus (HPV) deregulation of Toll-like receptor 9Uzma HasanMethods in Molecular Biology (Clifton, N.J.)|January 9, 2019
The Astrocyte-Neuron Interface: An Overview on Molecular and Cellular Dynamics Controlling Formation and Maintenance of the Tripartite SynapseUzma Hasan, Sandeep K SinghACS Applied Bio Materials|November 17, 2023
Reversal of Multidrug Resistance by the Synergistic Effect of Reversan and Hyperthermia to Potentiate the Chemotherapeutic Response of Doxorubicin in Glioblastoma and Glioblastoma Stem CellsUzma Hasan, Eerappa Rajakumara, Jyotsnendu GiriThe Journal of Pediatric Pharmacology and Therapeutics : JPPT : the Official Journal of PPAG|July 28, 2025
Meropenem/Vaborbactam in Pediatrics: 2 Cases of CRE Intraabdominal InfectionUgene Sano, Rachel Meyers, Uzma Hasan, et al.Frontiers in Neuroscience|March 20, 2023
Viral-induced neuroinflammation: Different mechanisms converging to similar exacerbated glial responsesBrenda Rocamonde, Uzma Hasan, Cyrille Mathieu, et al.European Journal of Immunology|September 8, 2016
Back to the drawing board: Understanding the complexity of hepatic innate lymphoid cellsMarie Marotel, Uzma Hasan, Sébastien Viel, et al.Progress in Biomaterials|July 5, 2021
Cell encapsulated and microenvironment modulating microbeads containing alginate hydrogel system for bone tissue engineeringInduvahi Veernala, Purandhi Roopmani, Ruby Singh, et al.European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|December 30, 2023
Airbrushed nanofibers with bioactive core and antibacterial shell for wound healing applicationRuby Singh, Purandhi Roopmani, Uzma Hasan, et al.Targeted Oncology|March 9, 2012
Targeting pattern recognition receptors in cancer immunotherapyNadège Goutagny, Yann Estornes, Uzma Hasan, et al.Drug Delivery and Translational Research|August 16, 2023
Overcoming multidrug resistance by reversan and exterminating glioblastoma and glioblastoma stem cells by delivering drug-loaded nanostructure hybrid lipid capsules (nHLCs)Uzma Hasan, Meenakshi Chauhan, Suparna Mercy Basu, et al.Pageof 4